$GBTG

OHara Michael Gregory sold (to issuer) 19,964,270 shares of GBTG (indirect holdings)

OHara Michael Gregory sold (to issuer) 19,964,270 indirectly-held shares of Global Business Travel Group, Inc. (GBTG) on 2026-09-29.

Original reporting
SEC EDGAR · OHara Michael Gregory
Published Sep 29, 2026, 8:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 8:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GBTG
Bearish
medium confidence
Mentioned
$GBTG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GBTGBearishLow
01

Why it matters

The director's complete divestiture removes his ownership stake, potentially influencing market perception of the company's outlook.

02

Market read

A sizable insider sell can trigger short‑term price pressure, especially in a thinly traded small‑cap stock.

03

What to watch

No disclosed sale price; the transaction may have been executed at a premium or as part of a pre‑arranged plan.

Relevance 4/10Novelty 4/10Timing: post‑market on 2026‑09‑29

Background

Form 4 filings disclose insider transactions and are primary sources for corporate governance monitoring.

Company-level read

Ticker impact

$GBTGBearishMedium confidence
Context

Director Michael Gregory sold 19,964,270 shares of Global Business Travel Group, Inc. (GBTG) via a Form 4 filing.

Expected impact

likely downward pressure as investors price in the sizable insider sale

Evidence & confidence

The sale represents a substantial stake (nearly 20 M shares) by a director, suggesting potential concerns about future performance.

Market effects

Travel and expense‑management sector may see modest scrutiny as insider activity highlights governance risk.

U.S. equity markets could see slight negative bias in small‑cap travel stocks.

Limited; impact confined to the issuer and its immediate peers.

Counterpoint

The sale could be a routine liquidity event unrelated to fundamentals, offering a buying opportunity at a discounted price.

Key entities

  • Global Business Travel Group, Inc.

    U.S. travel‑services provider listed as GBTG.

  • Michael Gregory

    Director of GBTG who sold his shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HRLMedAI 8/10

Deal Dispatch: Hormel Acquires Brakebush, Onsemi buys Synaptics for $5.7 Billion, Leslie’s Pools Bankrupt

Hormel (HRL) acquires Brakebush for $1.06B; Onsemi (ON) to buy Synaptics for $5.7B; Leslie's files for bankruptcy. Valley National (VLY) to acquire Bluevine for $340M. Yext (YEXT) to acquire Flamel.ai. Lifecore (LFCR) to be acquired by Webster Equity for up to $663.7M. SoftBank completes DigitalBridge acquisition. GBTG acquired by Long Lake for $6.3B.

$INTUMed

Q2 Earnings Highs And Lows: Intuit (NASDAQ:INTU) Vs The Rest Of The Finance and HR Software Stocks

Intuit (INTU) reported Q2 revenue of $4.35B, up 13.7% YoY, but missed EPS guidance, causing shares to drop 12.5%. American Express Global Business Travel (GBTG) saw 37.9% revenue growth, beating estimates. Marqeta (MQ) reported $176M revenue, up 17% YoY, but missed guidance. Paylocity (PCTY) beat estimates with 11% growth. BlackLine (BL) reported $187.8M revenue, in line with expectations but down 13.2% post-earnings.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).